Literature DB >> 29205675

Exploring associations between psychiatric disorder, psychological distress, and health care utilization in cancer patients.

F R Compen1, E M M Adang2, E M Bisseling1,3, M L Van der Lee3, A E M Speckens1.   

Abstract

OBJECTIVE: The mental burden of cancer might elicit additional health care utilization. However, it is unclear how psychiatric disorder and psychological distress relate to health care utilization. Therefore, this study explores associations between psychiatric disorder, psychological distress, and health care utilization. It was hypothesized that presence of psychiatric disorder and psychological distress was associated with increased health care utilization and costs.
METHODS: The current study consisted of secondary analyses of baseline data of a larger randomized controlled trial. Two hundred forty-five mixed-cancer patients with at least mild symptoms of psychological distress (Hospital Anxiety and Depression Scale-T ≥ 11) were mainly recruited via online media, participating centers and patient associations. Patients were assessed with Structured Clinical Interview for DSM-IV-TR Axis I Disorders (SCID-I) for depressive, anxiety, and/or adjustment disorder. Psychological distress was measured by the Hospital Anxiety and Depression Scale. Retrospective self-reported health care utilization in the past 3 months was collected. Associations between predictors and health care utilization in terms of incidence rate ratios (IRR) and costs per category (mental, primary, somatic, and complementary) were assessed by negative binomial, logistic, and gamma regression.
RESULTS: Eighty-nine (36.3%) patients suffered from psychiatric disorder, which was associated with mental health care utilization (IRR = 1.63) and costs (OR = 3.11). We observed a nonsignificant trend of somatic health care utilization in patients with psychiatric disorder. Psychological distress was associated with mental health care utilization (IRR = 1.09) and costs (OR = 1.09). Psychological distress was also associated with complementary health care utilization (IRR = 1.03).
CONCLUSION: Psychiatric disorder and psychological distress were associated with mental health care use and costs. Psychological distress was associated with complementary health care use. Adequate assessment and referral to mental health care might prevent unnecessary health care utilization.
Copyright © 2017 John Wiley & Sons, Ltd.

Entities:  

Keywords:  cancer; health care utilization; oncology; psychiatric disorder; psychological distress

Mesh:

Year:  2018        PMID: 29205675     DOI: 10.1002/pon.4591

Source DB:  PubMed          Journal:  Psychooncology        ISSN: 1057-9249            Impact factor:   3.894


  4 in total

1.  Screening for Distress in Oncological Patients: The Revised Version of the Psychological Distress Inventory (PDI-R).

Authors:  Alessandro Alberto Rossi; Maria Marconi; Federica Taccini; Claudio Verusio; Stefania Mannarini
Journal:  Front Psychol       Date:  2022-05-06

2.  Economic evaluation of a combined screening and stepped-care treatment program targeting psychological distress in patients with metastatic colorectal cancer: A cluster randomized controlled trial.

Authors:  Mohamed El Alili; Claudia S E W Schuurhuizen; Annemarie M J Braamse; Aartjan T F Beekman; Mecheline H van der Linden; Inge R Konings; Joost Dekker; Judith E Bosmans
Journal:  Palliat Med       Date:  2020-04-29       Impact factor: 4.762

Review 3.  Psychological problems among cancer patients in relation to healthcare and societal costs: A systematic review.

Authors:  Florie E Van Beek; Lonneke M A Wijnhoven; Karen Holtmaat; José A E Custers; Judith B Prins; Irma M Verdonck-de Leeuw; Femke Jansen
Journal:  Psychooncology       Date:  2021-07-06       Impact factor: 3.955

4.  Cost-utility of individual internet-based and face-to-face Mindfulness-Based Cognitive Therapy compared with treatment as usual in reducing psychological distress in cancer patients.

Authors:  Félix Compen; Eddy Adang; Else Bisseling; Marije van der Lee; Anne Speckens
Journal:  Psychooncology       Date:  2019-12-26       Impact factor: 3.894

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.